Proposed approval of triptorelin acetate and registration of the product Elanco Ovugel (Triptorelin Acetate) gel for intravaginal use in sows

This consultation closed on 12 July 2016.
Consultation period: 
14 June 2016 to 12 July 2016

The APVMA is considering an application for the approval of triptorelin acetate and registration of Elanco Ovugel (Triptorelin Acetate) gel for intravaginal use in sows. The product is to be used for synchronisation of time of insemination in weaned sows to facilitate a single fixed time artificial insemination.

We invite written comment on the proposed approval of triptorelin acetate and registration of the product Elanco Ovugel (Triptorelin Acetate) gel for intravaginal use in sows on whether the application for approval of the active constituent and/or registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds for registration, including:

  • safety criteria
  • efficacy criteria
  • trade criteria.

For more information see APVMA Gazette notice (page 22) from 14 June 2016.

Please send your written submission by email, post or fax to:

Enquiries
Registration Management and Enquiries
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604

email: enquiries@apvma.gov.au
Fax: +61 2 6210 4721
Phone: +61 2 6210 4701

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.